These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29573622)

  • 41. Adolescents at risk: pain pills to heroin: part II.
    Fogger S; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):27-30. PubMed ID: 25654572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with illicit opioid use in methadone maintenance treatment clients in 5 Provinces, China.
    Li W; Wang Z; Liu Z
    Environ Health Prev Med; 2016 Nov; 21(6):480-486. PubMed ID: 27699691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
    Gibson A; Randall D; Degenhardt L
    Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study.
    Cousins G; Boland F; Courtney B; Barry J; Lyons S; Fahey T
    Addiction; 2016 Jan; 111(1):73-82. PubMed ID: 26234389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Socioeconomic and geographical disparities in prescription and illicit opioid-related overdose deaths in Orange County, California, from 2010-2014.
    Marshall JR; Gassner SF; Anderson CL; Cooper RJ; Lotfipour S; Chakravarthy B
    Subst Abus; 2019; 40(1):80-86. PubMed ID: 29465301
    [No Abstract]   [Full Text] [Related]  

  • 47. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
    Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
    Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances.
    Andersson L; Håkansson A; Krantz P; Johnson B
    Harm Reduct J; 2020 Jan; 17(1):5. PubMed ID: 31918732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008.
    Rosca P; Haklai Z; Goldberger N; Zohar P; Margolis A; Ponizovsky AM
    Drug Alcohol Depend; 2012 Sep; 125(1-2):160-3. PubMed ID: 22483811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospitalizations for opioid poisoning: a nation-wide population-based study in Denmark, 1998-2004.
    Bjørn AM; Jepsen P; Larsson HJ; Thomsen HF; Kieler H; Ehrenstein V; Christensen S
    Addiction; 2009 Jan; 104(1):104-8. PubMed ID: 19133894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender differences in mortality among treated opioid dependent patients.
    Evans E; Kelleghan A; Li L; Min J; Huang D; Urada D; Hser YI; Nosyk B
    Drug Alcohol Depend; 2015 Oct; 155():228-35. PubMed ID: 26282107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Commentary: decline in methadone-related deaths probably relates to increased supervision of methadone in UK.
    Zador D; Mayet S; Strang J
    Int J Epidemiol; 2006 Dec; 35(6):1586-7. PubMed ID: 17244713
    [No Abstract]   [Full Text] [Related]  

  • 57. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.
    Merrall EL; Bird SM; Hutchinson SJ
    Int J Drug Policy; 2012 Jan; 23(1):24-32. PubMed ID: 21719267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations.
    Baldacchino A; Tolomeo S; Balfour DJ; Matthews K
    Psychol Med; 2019 May; 49(7):1174-1184. PubMed ID: 30457069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
    Bretteville-Jensen AL; Lillehagen M; Gjersing L; Andreas JB
    Drug Alcohol Depend; 2015 Feb; 147():89-96. PubMed ID: 25543167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.